A phase II trial of prolonged, continuous infusion of low-dose gemcitabine plus cisplatin in patients with advanced malignant pleural mesothelioma

被引：0
|
作者：
Oscar Arrieta
Diego López-Macías
Víctor-Osvaldo Mendoza-García
Ludwing Bacon-Fonseca
Wendy Muñoz-Montaño
Eleazar-Omar Macedo-Pérez
Saé Muñiz-Hernández
Monika Blake-Cerda
José-Francisco Corona-Cruz
机构：
[1] Instituto Nacional de Cancerología (INCan),Thoracic Oncology Unit, Experimental Oncology Laboratory
来源：
Cancer Chemotherapy and Pharmacology | 2014年 / 73卷
关键词：
Mesothelioma; Prolonged infusion; Gemcitabine; Cisplatin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：975 / 982
页数：7
相关论文
共 50 条
  • [1] A phase II trial of prolonged, continuous infusion of low-dose gemcitabine plus cisplatin in patients with advanced malignant pleural mesothelioma
    Arrieta, Oscar
    Lopez-Macias, Diego
    Mendoza-Garcia, Victor-Osvaldo
    Bacon-Fonseca, Ludwing
    Munoz-Montano, Wendy
    Macedo-Perez, Eleazar-Omar
    Muniz-Hernandez, Sae
    Blake-Cerda, Monika
    Corona-Cruz, Jose-Francisco
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 73 (05) : 975 - 982
  • [2] A phase II trial of prolonged, continuous infusion of low-dose gemcitabine plus cisplatin in patients with advanced malignant pleural mesothelioma.
    Rodriguez, Oscar
    Lopez, Diego
    Osvaldo Mendoza-Garcia, Victor
    Bacon Fonseca, Ludwing Alexander
    Munoz-Montano, Wendy
    Macedo, Omar
    Muniz-Hernandez, Sae
    Blake, Monika
    Corona, Jose F.
    De La Garza, Jaime G.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [3] A phase II trial of low-dose gemcitabine in a prolonged infusion and cisplatin for malignant pleural mesothelioma
    Kovac, Viljem
    Zwitter, Matjaz
    Rajer, Mirjana
    Marin, Aleksander
    Debeljak, Andrej
    Smrdel, Uros
    Vrankar, Martina
    [J]. ANTI-CANCER DRUGS, 2012, 23 (02) : 230 - 238
  • [4] Low-dose gemcitabine in prolonged infusion and cisplatin for malignant pleural mesothelioma: a phase I and II trials
    Kovac, V
    Zwitter, M
    Smrdel, U
    Debeljak, A
    Cesar, R
    Izidor, K
    [J]. LUNG CANCER, 2004, 45 : S68 - S68
  • [5] LOW-DOSE GEMCITABINE IN PROLONGED INFUSION AND CISPLATIN FOR THE TREATMENT OF MALIGNANT PLEURAL MESOTHELIOMA
    Kovac, Vilijem
    Zwitter, Matjaz
    Rajer, Mirjana
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1359 - S1360
  • [6] Low-dose gemcitabine in prolonged infusion and cisplatin for malignant pleural mesothelioma: a phase I-IItrial
    Kovac, V
    Zwitter, M
    Smrdel, U
    Debeljak, A
    Cesar, R
    [J]. PROCEEDINGS OF THE 9TH CENTRAL EUROPEAN LUNG CANCER CONFERENCE, 2004, : 131 - 134
  • [7] Efficacy, Safety, and Cost-Minimization Analysis of Continuous Infusion of Low-Dose Gemcitabine Plus Cisplatin in Patients With Unresectable Malignant Pleural Mesothelioma
    Arrieta, Oscar
    Munoz-Montano, Wendy
    Muniz-Hernandez, Sae
    Campos, Saul
    Catalan, Rodrigo
    Soto-Molina, Herman
    Guzman Vazquez, Silvia
    Diaz-Alvarez, Osvaldo
    Martinez-Pacheco, Victor
    Turcott, Jenny G.
    Ramos-Ramirez, Maritza
    Cabrera-Miranda, Luis
    Barron, Feliciano
    Cardona, Andres F.
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [8] A phase II trial of low dose prolonged infusion gemcitabine and cisplatin in advanced bladder cancer
    Khaled, Hussein M.
    El-Khodary, Ahmed I.
    Emara, Mohamed E.
    Gaafar, Rabab M.
    Mansour, Osman
    Warith, Amed Abdei
    Zaghloul, Mohamed S.
    El Malt, Osama
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 118 - 118
  • [9] RRM1 and ERCC1 as biomarkers in patients with locally advanced and metastatic malignant pleural mesothelioma treated with continuous infusion of low-dose gemcitabine plus cisplatin
    Munoz-Montano, Wendy
    Muniz-Hernandez, Sae
    Aviles-Salas, Alejandro
    Catalan, Rodrigo
    Lara-Mejia, Luis
    Samtani-Bassarmal, Suraj
    Cardona, Andres F.
    Mendoza-Desion, Jorge
    Hernandez-Cueto, Daniel
    Maldonado, Altagracia
    Baay-Guzman, Guillermina
    Huerta-Yepes, Sara
    Arrieta, Oscar
    [J]. BMC CANCER, 2021, 21 (01)
  • [10] RRM1 and ERCC1 as biomarkers in patients with locally advanced and metastatic malignant pleural mesothelioma treated with continuous infusion of low-dose gemcitabine plus cisplatin
    Wendy Muñoz-Montaño
    Sae Muñiz-Hernández
    Alejandro Avilés-Salas
    Rodrigo Catalán
    Luis Lara-Mejía
    Suraj Samtani-Bassarmal
    Andres F. Cardona
    Jorge Mendoza-Desión
    Daniel Hernández-Cueto
    Altagracia Maldonado
    Guillermina Baay-Guzmán
    Sara Huerta-Yepes
    Oscar Arrieta
    [J]. BMC Cancer, 21
12345